Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Hazra

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
The Pediatric Infectious Disease Journal|May 12, 2015
Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected ChildrenSarah K Himes, Julia W Wu, Denise L Jacobson, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|September 5, 2009
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of PediatricsLynne M Mofenson, Michael T Brady, Susie P Danner, et al.
The Pediatric Infectious Disease Journal|December 20, 2012
Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infectionMurli Purswani, Kunjal Patel, Jeffrey B Kopp, et al.
Plos One|June 15, 2016
The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected YouthAnna-Barbara Moscicki, Tzy-Jyun Yao, Mark I Ryder, et al.
Frontiers in Genetics|December 3, 2013
Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding proteinTravis R Porter, Xuelin Li, Charles B Stephensen, et al.
JAMA Pediatrics|November 11, 2014
Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infantsPaige L Williams, Marilyn J Crain, Cenk Yildirim, et al.
Journal of the International AIDS Society|July 30, 2020
Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortiumGabriela Patten, Thanyawee Puthanakit, Catherine C McGowan, et al.
Plos One|May 21, 2021
Outcomes of retained and disengaged pregnant women living with HIV in UgandaAgnes N Kiragga, Ellon Twinomuhwezi, Grace Banturaki, et al.
AIDS Research and Human Retroviruses|March 22, 2017
Blood lead levels and neurodevelopmental function in perinatally HIV-exposed, uninfected children in a US-based longitudinal cohort studyKatherine Tassiopoulos, Yanling Huo, Joseph Braun, et al.
Pediatrics|August 23, 2006
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected childrenRachel I Gafni, Rohan Hazra, James C Reynolds, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
The Pediatric Infectious Disease Journal|May 12, 2015
Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected ChildrenSarah K Himes, Julia W Wu, Denise L Jacobson, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|September 5, 2009
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of PediatricsLynne M Mofenson, Michael T Brady, Susie P Danner, et al.
The Pediatric Infectious Disease Journal|December 20, 2012
Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infectionMurli Purswani, Kunjal Patel, Jeffrey B Kopp, et al.
Plos One|June 15, 2016
The Burden of Oral Disease among Perinatally HIV-Infected and HIV-Exposed Uninfected YouthAnna-Barbara Moscicki, Tzy-Jyun Yao, Mark I Ryder, et al.
Frontiers in Genetics|December 3, 2013
Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding proteinTravis R Porter, Xuelin Li, Charles B Stephensen, et al.
JAMA Pediatrics|November 11, 2014
Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infantsPaige L Williams, Marilyn J Crain, Cenk Yildirim, et al.
Journal of the International AIDS Society|July 30, 2020
Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortiumGabriela Patten, Thanyawee Puthanakit, Catherine C McGowan, et al.
Plos One|May 21, 2021
Outcomes of retained and disengaged pregnant women living with HIV in UgandaAgnes N Kiragga, Ellon Twinomuhwezi, Grace Banturaki, et al.
AIDS Research and Human Retroviruses|March 22, 2017
Blood lead levels and neurodevelopmental function in perinatally HIV-exposed, uninfected children in a US-based longitudinal cohort studyKatherine Tassiopoulos, Yanling Huo, Joseph Braun, et al.
Pediatrics|August 23, 2006
Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected childrenRachel I Gafni, Rohan Hazra, James C Reynolds, et al.
Pageof 15